Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Similar documents
Revised 16 February, of 7

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City

PL CE LIVE: Overdose Prevention with Naloxone Opportunities for Pharmacists May 2015

Naloxone Standing Order for Opioid Overdose

Opiate Overdose Treatment: Naloxone Training Protocol

Opioid Harm Reduction

Pennsylvania DEPARTMENT OF HEALTH

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE

Welcome to the Opioid Overdose Prevention Project

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know

NALOXONE: HEALTHCARE PROFESSIONALS TRAINING GUIDE FOR ADMINISTRATION AND DISPENSING

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background

Opioids and Overdose 2017

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Sierra Sacramento Valley EMS Agency

Calvert County Health Department Overdose Education and Naloxone Training

How to Prevent an Opioid Overdose

Naloxone and Combating the Opioid Epidemic

Braintree Public Schools

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health

Pharmacist Learning Objectives

Drug Class Review: Opioid Reversal Agents

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

First Responder Naloxone Grant Webinar

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Using your Take Home Naloxone Kit

NALOXONE CAN BE A LIFESAVER

Medical Directive. Medical Director: Date Revised: January 1, Executive Director: Date Revised: January 1, 2019

Protocol For: Personally Furnishing Naloxone. Update Log

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Pharmacist Directed Opioid Antagonist Dispensing

The Use of Naloxone in Workers Compensation. A Workers Compensation Continuing Education Course

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services

Drug Overdose Prevention Program (DOPP)

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

????? PL CE LIVE Special Edition: Overdose Prevention with Naloxone Opportunities for Pharmacists. Objectives. Questions We ll Answer Today

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017

NALOXONE CAN BE A LIFESAVER

Take Home Naloxone elearning Module Script

Opioid Safety: Focus on Furnishing Naloxone

Naloxone: What You Need to Know About Overdose Reversal In the Midst of an Opioid Epidemic

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance

NALOXONE RISK ASSESSMENT

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND

Prescription Opioids

Naloxone Administration Training

The Solution. A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including:

Dosage. Hospira Mylan Amphastar Amphastar syringe Teleflex (nasal adapter) 0.4 mg/ml 4 mg/10 ml. 1mg/mL (2mg/2mL) Nov (b)(2) Narcan Nasal

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms

Overdose Response Training

Naloxone in Schools. Training for School Staff

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018

Opioids - Fentanyl - Naloxone. Public Health Nurse

A Conversation on Fentanyl. School District 22 VERNON

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

2/20/2017 NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE DISCLOSURES LEARNING OBJECTIVES

PATIENT GROUP DIRECTION (PGD)

TO YOUR PHARMACIST TOOLKIT. A Guide to Help Utah Pharmacists Talk to Customers About Prescription Opioids

Opioid Overdose Education and Naloxone Distribution

Naloxone Opioid Overdose Reversal Collaborative Drug Therapy Agreement

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region

MEDICATION ASSISTED TREATMENT

Opioid Safety: Focus on Furnishing Naloxone A GUIDE FOR CALIFORNIA COMMUNITY PHARMACISTS

NALOXONE (NARCAN) POLICY

Overdose. Everything you need to know. Includes free DVD!

POWER TO HELP REVERSE AN OPIOID OVERDOSE

How to Save a Life: Naloxone for the Treatment of Opioid Overdose

People inject, sniff, snort, or smoke heroin. Some people mix heroin with crack cocaine, a practice called speedballing.

Addressing the Opioid Epidemic Naloxone and its Role in Prevention of Opioid Overdose Death May 24, 2018

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE

Naloxone Opioid Rescue Kits. Aaron Kochar, JD

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Overdose Prevention, Recognition & Response Education Train-the-Trainer

Opiate Morbidity & Mortality: What s the Problem & What Can You Do About It?

ADMINISTRATIVE REQUIREMENT MANUAL EFFECTIVE DATE

Clinical Policy: Naloxone (Evzio) Reference Number: CP.PMN.139 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

Anyone Can Become Addicted. Anyone.

Community Pharmacy Distribution of Naloxone

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. September 2016 TRANSCRIPT

Let s Talk About. Pain Medicines. wisconsin. health literacy. A division of Wisconsin Literacy, Inc.

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014

PMP Advisory Committee. Chair: Sarah Pointer, Pharm D. PMP Admin: Craig Berberet September 20, 2017

Training of Trainers Maryland Overdose Response Program

Safe Job Procedure Overdose Prevention Injectable Naloxone

Substance Misuse and Abuse

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer,

Safe Use, Storage, and Disposal of Opioid Drugs Safe Use, Storage, and Disposal of Opioid Drugs

Harm Reduction Coalition DOPE Project Eliza Wheeler 1440 Broadway Suite 902 Oakland, CA

Transcription:

THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any pharmacist practicing in the State of South Carolina and licensed by the South Carolina Board of Pharmacy to dispense the following Naloxone Hydrochloride products to persons without a prescription as directed below pursuant to 44 130 40 of the South Carolina Code of Laws. Eligible candidates Naloxone HCI Dispensing Protocol Persons who voluntarily request Naloxone and are at risk of experiencing opioid related overdose, including but not limited to: Current illicit or non medical opioid users or persons with a history of such use; Persons with a history of opioid intoxication or overdose and/or emergency medical care for acute opioid poisoning; Persons with an opioid prescription, especially those who have: known or suspected concurrent alcohol abuse; COPD or other respiratory illness or obstruction or currently smoke; renal dysfunction, Hepatic disease, cardiac disease, or HIV/AIDS; or concurrent Benzodiazepine prescription; Persons from an opioid detoxification and mandatory abstinence program; Persons entering methadone maintenance treatment programs (for addiction or pain); Persons who may have difficulty accessing emergency medical services; and/or Persons who voluntarily request Naloxone and are the caregiver of a person at risk of experiencing an opioid overdose. Route(s) of administration Intranasal (IN) Preferred method Medication and required Naloxone HCl 1 mg/ml Inj. device for administration 2 x 2 ml as pre filled Luer Lock syringes Dispense 2 (two) doses 2 (two) x Intranasal Mucosal Atomizing Devices (MAD 300) Naloxone HCI 4 mg/0.1 ml Nasal Spray Dispense 1 x two pack Intramuscular (IM) Inject into shoulder or thigh Naloxone HCI 0.4mg/mL Inj. 2 x 1mL single dose vials (SDV) Dispense 2 (two) SDV 2 (two) x intramuscular (IM) syringe, 3mL, 25 G, 1 inch Directions for use Spray 1 ml in each nostril. Repeat after 3 minutes if minimal or no response. Refills Contraindications Patient education Pharmacist education Administer a single spray of Naloxone HCI in one nostril. Repeat after 3 minutes if minimal or no response. Naloxone HCl auto injector Inject 1 ml IM in shoulder or thigh. Repeat after 3 minutes if minimal or no response. PRN A history of known hypersensitivity to Naloxone or any of its components Every person dispensed Naloxone shall receive education regarding the risk factors of overdose, signs of an overdose, overdose response steps, and the use of Naloxone. Examples of education materials that incorporate the above information may be found at http://www.naloxonesavessc.org and attached hereto in Appendix A. Pharmacists should be sufficiently educated regarding the Naloxone HCl product(s) being dispensed to provide appropriate counseling to the persons receiving the medication, as required by S.C. Code Ann. 40 43 30(14). Suggested training resources are identified in Appendix B attached hereto and may be found on http://www.naloxonesavessc.org. Notification of participation Required documentation Pharmacies choosing to participate in the Naloxone distribution may notify the State Board of Pharmacy when initiating their participation. See directions for notification at http://www.naloxonesavessc.org. A current copy of the Joint Protocol to Initiate Dispensing of Naloxone HCl Without a Prescription, if participating; Notice of Informed Consent and Affirmation of Naloxone Purchaser with Notice to Primary Care Provider, if identified, for each transaction; and All pertinent patient records relative to dispensing of Naloxone HCl without a prescription, which must be maintained for a period of 2 years. Stephen R. Gardner, MD Carole S. Russell, R.Ph. President, SC Board of Medical Examiners Chairman, SC Board of Pharmacy November 17, 2016 November 17, 2016

APPENDIX A EDUCATIONAL MATERIALS FOR NALOXONE PURCHASERS 1. Educational Tri fold for Autoinjector 2. Educational Tri fold for Injectable Naloxone 3. Educational Tri fold for Mucosal Atomizing Devices (MAD 300) 4. Educational Tri fold for Nasal Narcan

SUMMARY: EVZIO AUTO INJECTOR 1. Identify overdose 2. Call 9 1 1 3. Give naloxone 4. CPR 5. Stay until help arrives For assistance with finding substance abuse treatment, support groups, or recovery support services in your community please call: 1 800 662 HELP (4357) Naloxone Saves South Carolina

Naloxone What is naloxone? Naloxone is a remedy for opioid overdose. In an overdose, opioids slow and stop breathing and cause sedation that can lead to death. Naloxone is a medication that reverses the effects that lead to death. Opioids may include prescription medications (eg, oxycodone, fentanyl, hydrocodone, etc.) or heroin. Step 1: IDENTIFY OVERDOSE Opioids can be dangerous because they can suppress breathing, which may lead to death. If someone is not breathing or is struggling to breathe after taking opioids, try calling the victim s name and rubbing your knuckles on their chest. If the victim does not respond he or she may be experiencing an overdose. Other signs that may help you identify an overdose are: blue or pale skin color, small pupils, low blood pressure, slow heartbeat, slow or shallow breathing, snoring sound, gasping for breath. Step 4: BEGIN CPR If the victim is still unresponsive with no breathing or only gasping, begin CPR with rescue breathing. Make sure nothing is in the victim s mouth blocking their breathing. Place one hand on the chin and tilt the head back. With the other hand pinch the nose closed. Administer two slow breaths and look for the chest to rise. Continue administering 1 breath every 5 seconds until the victim starts breathing on his or her own. If victim no longer has a pulse, administer chest compressions in addition to rescue breathing. Who should take naloxone? Naloxone only works if opioids are in the body; it has no effect if they are not. It does not work on effects of other drugs or alcohol. Naloxone may take effect in 3 to 5 minutes and can last up to 60 to 90 minutes. Step 2: CALL 9 1 1 When you think an overdose is happening, get help as quickly as possible. Call 9 1 1. Be sure to say the victim is unresponsive and not breathing or is struggling to breathe. Give a clear address and location. Also send for Automated External Defibrillator (AED) and naloxone. Step 3: GIVE NALOXONE Naloxone is available as a nasal spray or injection. See specific products for administration instructions. If the first dose is unsuccessful in three minutes or begins to wear off, administer a second dose. Store naloxone in an easy to reach place, in case of emergency. Make sure your friends and family know where it is stored. If the victim is breathing, move them to the recovery position. Step 5: STAY UNTIL HELP ARRIVES It is important to stay with someone after giving naloxone. Naloxone can reverse an overdose, but can also cause withdrawal symptoms including but not limited to: restlessness, nervousness, nausea and vomiting. Recovery Position

INJECTABLE NALOXONE 1. Remove cap from naloxone vial and uncover the needle. SUMMARY: 1. Identify overdose 2. Call 9 1 1 3. Give naloxone 4. CPR 5. Stay until help arrives 2. Insert needle through rubber plug with vial upside down. Pull back on plunger and take up 1 ml. For assistance with finding substance abuse treatment, support groups, or recovery support services in your community please call: 1 800 662 HELP (4357) Naloxone Saves South Carolina 3. Inject 1 ml of naloxone at a 90 degree angle into a large muscle (upper arm/thigh, outer buttocks).

Naloxone What is naloxone? Naloxone is a remedy for opioid overdose. In an overdose, opioids slow and stop breathing and cause sedation that can lead to death. Naloxone is a medication that reverses the effects that lead to death. Opioids may include prescription medications (eg, oxycodone, fentanyl, hydrocodone, etc.) or heroin. Step 1: IDENTIFY OVERDOSE Opioids can be dangerous because they can suppress breathing, which may lead to death. If someone is not breathing or is struggling to breathe after taking opioids, try calling the victim s name and rubbing your knuckles on their chest. If the victim does not respond he or she may be experiencing an overdose. Other signs that may help you identify an overdose are: blue or pale skin color, small pupils, low blood pressure, slow heartbeat, slow or shallow breathing, snoring sound, gasping for breath. Step 4: BEGIN CPR If the victim is still unresponsive with no breathing or only gasping, begin CPR with rescue breathing. Make sure nothing is in the victim s mouth blocking their breathing. Place one hand on the chin and tilt the head back. With the other hand pinch the nose closed. Administer two slow breaths and look for the chest to rise. Continue administering 1 breath every 5 seconds until the victim starts breathing on his or her own. If victim no longer has a pulse, administer chest compressions in addition to rescue breathing. Who should take naloxone? Naloxone only works if opioids are in the body; it has no effect if they are not. It does not work on effects of other drugs or alcohol. Naloxone may take effect in 3 to 5 minutes and can last up to 60 to 90 minutes. Step 2: CALL 9 1 1 When you think an overdose is happening, get help as quickly as possible. Call 9 1 1. Be sure to say the victim is unresponsive and not breathing or is struggling to breathe. Give a clear address and location. Also send for Automated External Defibrillator (AED) and naloxone. Step 3: GIVE NALOXONE Naloxone is available as a nasal spray or injection. See specific products for administration instructions. If the first dose is unsuccessful in three minutes or begins to wear off, administer a second dose. Store naloxone in an easy to reach place, in case of emergency. Make sure your friends and family know where it is stored. If the victim is breathing, move them to the recovery position. Step 5: STAY UNTIL HELP ARRIVES It is important to stay with someone after giving naloxone. Naloxone can reverse an overdose, but can also cause withdrawal symptoms including but not limited to: restlessness, nervousness, nausea and vomiting. Recovery Position

NARCAN NASAL SPRAY SUMMARY: 1. Identify overdose 2. Call 9 1 1 3. Give naloxone 4. CPR 5. Stay until help arrives For assistance with finding substance abuse treatment, support groups, or recovery support services in your community please call: 1 800 662 HELP (4357) Naloxone Saves South Carolina

Naloxone What is naloxone? Naloxone is a remedy for opioid overdose. In an overdose, opioids slow and stop breathing and cause sedation that can lead to death. Naloxone is a medication that reverses the effects that lead to death. Opioids may include prescription medications (eg, oxycodone, fentanyl, hydrocodone, etc.) or heroin. Step 1: IDENTIFY OVERDOSE Opioids can be dangerous because they can suppress breathing, which may lead to death. If someone is not breathing or is struggling to breathe after taking opioids, try calling the victim s name and rubbing your knuckles on their chest. If the victim does not respond he or she may be experiencing an overdose. Other signs that may help you identify an overdose are: blue or pale skin color, small pupils, low blood pressure, slow heartbeat, slow or shallow breathing, snoring sound, gasping for breath. Step 4: BEGIN CPR If the victim is still unresponsive with no breathing or only gasping, begin CPR with rescue breathing. Make sure nothing is in the victim s mouth blocking their breathing. Place one hand on the chin and tilt the head back. With the other hand pinch the nose closed. Administer two slow breaths and look for the chest to rise. Continue administering 1 breath every 5 seconds until the victim starts breathing on his or her own. If victim no longer has a pulse, administer chest compressions in addition to rescue breathing. Who should take naloxone? Naloxone only works if opioids are in the body; it has no effect if they are not. It does not work on effects of other drugs or alcohol. Naloxone may take effect in 3 to 5 minutes and can last up to 60 to 90 minutes. Step 2: CALL 9 1 1 When you think an overdose is happening, get help as quickly as possible. Call 9 1 1. Be sure to say the victim is unresponsive and not breathing or is struggling to breathe. Give a clear address and location. Also send for Automated External Defibrillator (AED) and naloxone. Step 3: GIVE NALOXONE Naloxone is available as a nasal spray or injection. See specific products for administration instructions. If the first dose is unsuccessful in three minutes or begins to wear off, administer a second dose. Store naloxone in an easy to reach place, in case of emergency. Make sure your friends and family know where it is stored. If the victim is breathing, move them to the recovery position. Step 5: STAY UNTIL HELP ARRIVES It is important to stay with someone after giving naloxone. Naloxone can reverse an overdose, but can also cause withdrawal symptoms including but not limited to: restlessness, nervousness, nausea and vomiting. Recovery Position

NARCAN NASAL SPRAY SUMMARY: 1. Identify overdose 2. Call 9 1 1 3. Give naloxone 4. CPR 5. Stay until help arrives Naloxone Saves For assistance with finding substance abuse treatment, support groups, or recovery support services in your community please call: 1 800 662 HELP (4357) South Carolina

Naloxone What is naloxone? Naloxone is a remedy for opioid overdose. In an overdose, opioids slow and stop breathing and cause sedation that can lead to death. Naloxone is a medication that reverses the effects that lead to death. Opioids may include prescription medications (eg, oxycodone, fentanyl, hydrocodone, etc.) or heroin. Step 1: IDENTIFY OVERDOSE Opioids can be dangerous because they can suppress breathing, which may lead to death. If someone is not breathing or is struggling to breathe after taking opioids, try calling the victim s name and rubbing your knuckles on their chest. If the victim does not respond he or she may be experiencing an overdose. Other signs that may help you identify an overdose are: blue or pale skin color, small pupils, low blood pressure, slow heartbeat, slow or shallow breathing, snoring sound, gasping for breath. Step 4: BEGIN CPR If the victim is still unresponsive with no breathing or only gasping, begin CPR with rescue breathing. Make sure nothing is in the victim s mouth blocking their breathing. Place one hand on the chin and tilt the head back. With the other hand pinch the nose closed. Administer two slow breaths and look for the chest to rise. Continue administering 1 breath every 5 seconds until the victim starts breathing on his or her own. If victim no longer has a pulse, administer chest compressions in addition to rescue breathing. Who should take naloxone? Naloxone only works if opioids are in the body; it has no effect if they are not. It does not work on effects of other drugs or alcohol. Naloxone may take effect in 3 to 5 minutes and can last up to 60 to 90 minutes. Step 2: CALL 9 1 1 When you think an overdose is happening, get help as quickly as possible. Call 9 1 1. Be sure to say the victim is unresponsive and not breathing or is struggling to breathe. Give a clear address and location. Also send for Automated External Defibrillator (AED) and naloxone. Step 3: GIVE NALOXONE Naloxone is available as a nasal spray or injection. See specific products for administration instructions. If the first dose is unsuccessful in three minutes or begins to wear off, administer a second dose. Store naloxone in an easy to reach place, in case of emergency. Make sure your friends and family know where it is stored. If the victim is breathing, move them to the recovery position. Step 5: STAY UNTIL HELP ARRIVES It is important to stay with someone after giving naloxone. Naloxone can reverse an overdose, but can also cause withdrawal symptoms including but not limited to: restlessness, nervousness, nausea and vomiting. Recovery Position

APPENDIX B SUGGESTED EDUCATIONAL RESOURCES FOR PHARMACISTS http://www.opioidprescribing.com/naloxone_module_1 landing https://cpnp.org/guideline/naloxone https://www.prescribetoprevent.org http://store.samhsa.gov/product/opioid Overdose Prevention Toolkit Updated 2016/SMA16 4742 https://www.evzio.com/ http://www.narcan.com/ https://scpa.memberclicks.net/assets/events/naloxone ondemand scpha%20code%202.pdf Regarding Intranasal Mucosal Atomizing Devices (MAD 300) availability: Teleflex (866 246 6990) or Safety Works, Inc. (800 723 3892)

Affirmation of Eligibility and Informed Consent for Naloxone Dispensed Without a Prescription Purchaser s Name: Purchaser s Address: Purchaser s Date of Birth: APPENDIX C AFFIRMATION OF ELIGIBILITY AND INFORMED CONSENT FOR NALOXONE DISPENSED WITHOUT A PRESCRIPTION AFFIRMATION OF ELIGIBILITY TO PURCHASE NALOXONE By signing below, I hereby affirm that either: I am at risk of experiencing an opioid related overdose. I have received patient overdose information, including risk factors of overdose, signs of an overdose, overdose response steps, and information about the use of Naloxone from the pharmacist dispensing Naloxone to me. OR I am not personally at risk of an opioid related overdose, but I am the caregiver of a person who is at risk of experiencing an opioid related overdose and am in a position to assist this person in the event of an opioid related overdose. I have received patient overdose information, including risk factors of overdose, signs of an overdose, overdose response steps, and information about the use of Naloxone from the pharmacist dispensing Naloxone to me. INFORMED CONSENT OF NALOXONE PURCHASER By signing below, I acknowledge that this pharmacy is providing Naloxone to me without a prescription based upon my affirmation of eligibility to purchase Naloxone. I understand the eligibility to purchase Naloxone without a prescription is not a substitute for an ongoing relationship with a primary care provider to address ongoing medical issues and opioid overdose prevention. I understand the pharmacy will provide the primary care provider I identify with records of the Naloxone purchase so that my medical records may be complete and that it is recommended that I take my personal records with me to my next appointment as well. I have received written materials or verbal instructions about the medication Naloxone. I understand the risks and benefits of using Naloxone, how to prevent and recognize an opioid overdose, and the importance of calling 911 emergency telephone services for medical assistance with an opioid overdose. I have been provided an opportunity to learn how to administer the correct dosage of Naloxone and ask questions, which have been answered to my satisfaction, and have been advised on how to care for an overdose victim after the administration of Naloxone. I wish to receive the Naloxone and hereby give consent for the dispensing pharmacist identified below to provide this document to the primary care practitioner, who is listed below.

Affirmation of Eligibility and Informed Consent for Naloxone Dispensed Without a Prescription Purchaser s Name: Purchaser s Address: Purchaser s Date of Birth: Naloxone Purchaser's Signature Date Naloxone Purchaser s Name Naloxone Purchaser s Date of Birth Naloxone Purchaser's Designated Primary Care Physician Name of Dispensing Pharmacist Contact Information for Dispensing Pharmacist